Cancer chemotherapy: new strategies for success.
作者信息
Berger N A
出版信息
J Clin Invest. 1986 Nov;78(5):1131-5. doi: 10.1172/JCI112692.
Abstract
摘要
相似文献
1
Cancer chemotherapy: new strategies for success.
J Clin Invest. 1986 Nov;78(5):1131-5. doi: 10.1172/JCI112692.
2
Chemotherapy for metastatic disease.
Symp Fundam Cancer Res. 1983;36:397-410.
3
New strategies in cancer chemotherapy.
Cell Biophys. 1986 Dec;9(1-2):243-56. doi: 10.1007/BF02797385.
4
[Chemotherapy of malignant tumors].
Arkh Patol. 1996 Jul-Aug;58(4):15-7.
5
[Current trends in the medical treatment of solid tumors].
An R Acad Nac Med (Madr). 1992;109(2):253-8.
6
Clinical hyperthermia combined with drugs and radiation. A phase I/II study.
Strahlenther Onkol. 1987 Jul;163(7):446-8.
7
High-dose chemotherapy.
Chemioterapia. 1987 Jun;6(2 Suppl):675-7.
8
Interactions of chemotherapy and radiation.
Semin Oncol. 1993 Feb;20(1):70-9.
9
[US-Japan Cooperative Cancer Research Program--adjuvant and neo-adjuvant chemotherapy].
Gan To Kagaku Ryoho. 1987 Apr;14(4):1175-9.
10
[Induced hypertension chemotherapy combined with radiotherapy in 44 advanced cancer patients].
Gan No Rinsho. 1986 Aug;32(9):981-6.
引用本文的文献
1
NIR and Reduction Dual-Sensitive Polymeric Prodrug Nanoparticles for Bioimaging and Combined Chemo-Phototherapy.
Polymers (Basel). 2022 Jan 11;14(2):287. doi: 10.3390/polym14020287.
2
Magnetic Resonance Imaging and Spectroscopy: Application to Experimental Neuro-Oncology.
Q Magn Reson Biol Med. 1994;1(2):89-106.
3
Oral buccoadhesive films of ondansetron: Development and evaluation.
Int J Pharm Investig. 2013 Apr;3(2):112-8. doi: 10.4103/2230-973X.114894.
4
Oxidation therapy: the use of a reactive oxygen species-generating enzyme system for tumour treatment.
Br J Cancer. 1994 Dec;70(6):1131-5. doi: 10.1038/bjc.1994.460.
5
Cytotoxic and antitumor effects of the norepinephrine analogue meta-iodo-benzylguanidine (MIBG).
Cancer Chemother Pharmacol. 1988;21(1):9-13. doi: 10.1007/BF00262730.
6
Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
Br J Cancer. 1989 Feb;59(2):247-50. doi: 10.1038/bjc.1989.50.
本文引用的文献
1
EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.
Cancer Chemother Rep. 1964 Feb;35:1-111.
2
Pyridine nucleotide metabolism: mechanism of action of the niacin antagonist, 6-aminonicotinamide.
J Biol Chem. 1958 Oct;233(4):964-8.
3
Inhibition of dihydrofolic reductase by aminopterin and amethopterin.
Proc Soc Exp Biol Med. 1958 Feb;97(2):429-31. doi: 10.3181/00379727-97-23764.
4
Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma.
Proc Soc Exp Biol Med. 1956 Nov;93(2):361-6. doi: 10.3181/00379727-93-22757.
5
5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer.
Ann Intern Med. 1980 Oct;93(4):533-6. doi: 10.7326/0003-4819-93-4-533.
6
Molecular pharmacology of the haloethyl nitrosoureas: formation of 6-hydroxyethylguanine in DNA treated with BCNU (N,N1-bis[2-chloroethyl]-N-nitrosourea).
Biochem Biophys Res Commun. 1981 May 15;100(1):351-7. doi: 10.1016/s0006-291x(81)80103-9.
7
DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells.
Nature. 1980 Dec 25;288(5792):727-9. doi: 10.1038/288727a0.
8
Dose: a critical factor in cancer chemotherapy.
Am J Med. 1980 Oct;69(4):585-94. doi: 10.1016/0002-9343(80)90472-6.
9
An overview of thymidine.
Cancer. 1980 Mar 15;45(5 Suppl):1117-28. doi: 10.1002/1097-0142(19800315)45:5+<1117::aid-cncr2820451316>3.0.co;2-s.
10
Removal of O6-methylguanine from DNA by human liver fractions.
Proc Natl Acad Sci U S A. 1982 Sep;79(17):5162-5. doi: 10.1073/pnas.79.17.5162.
Zotero 插件